AFT Pharmaceuticals Limited

NZSE:AFT Rapporto sulle azioni

Cap. di mercato: NZ$335.6m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

AFT Pharmaceuticals Crescita futura

Future criteri di controllo 3/6

AFT Pharmaceuticals prevede che gli utili e i ricavi cresceranno rispettivamente di 18.1% e 10.7% all'anno. Si prevede che l'EPS crescerà di 18% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 20% in 3 anni.

Informazioni chiave

18.1%

Tasso di crescita degli utili

18.0%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili54.5%
Tasso di crescita dei ricavi10.7%
Rendimento futuro del capitale proprio20.0%
Copertura analitica

Low

Ultimo aggiornamento15 Sep 2024

Aggiornamenti recenti sulla crescita futura

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Recent updates

It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

Jul 26
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

May 22
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Oct 17
Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

May 23
Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

Dec 01
Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

Jul 30
We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Jun 02
With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

Mar 20
Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Feb 13
A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 23
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Jan 02
Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

Dec 12
Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 21
AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Previsioni di crescita degli utili e dei ricavi

NZSE:AFT - Stime future degli analisti e dati finanziari passati (NZD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/20272852925N/A3
3/31/20262592517N/A3
3/31/20252241712N/A3
3/31/2024195161929N/A
12/31/2023185131221N/A
9/30/202317511413N/A
6/30/202316611312N/A
3/31/202315711212N/A
12/31/202214914412N/A
9/30/202214117613N/A
6/30/202213518714N/A
3/31/202213020914N/A
12/31/202112515712N/A
9/30/202112011510N/A
6/30/2021116906N/A
3/31/20211138-51N/A
12/31/20201105-43N/A
9/30/20201073-26N/A
6/30/20201077310N/A
3/31/202010612815N/A
12/31/201910011712N/A
9/30/2019941159N/A
6/30/201989415N/A
3/31/201985-3-21N/A
12/31/201884-7-5-1N/A
9/30/201883-11-8-4N/A
6/30/201882-12-10-6N/A
3/31/201881-14-12-9N/A
12/31/201779-14N/A-13N/A
9/30/201776-14N/A-16N/A
6/30/201773-16N/A-18N/A
3/31/201769-18N/A-19N/A
12/31/201667-18N/A-20N/A
9/30/201664-18N/A-21N/A
6/30/201664-16N/A-17N/A
3/31/201664-13N/A-14N/A
12/31/201563-13N/A-12N/A
9/30/201562-13N/A-10N/A
6/30/201559-13N/A-11N/A
3/31/201556-13N/A-13N/A
3/31/201449-1N/A0N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di AFT ( 18.1% all'anno) è superiore al tasso di risparmio ( 2.8% ).

Guadagni vs Mercato: Si prevede che gli utili di AFT ( 18.1% all'anno) cresceranno più rapidamente del mercato NZ ( 18% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di AFT cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di AFT ( 10.7% all'anno) crescerà più rapidamente del mercato NZ ( 4.2% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di AFT ( 10.7% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di AFT sarà basso tra 3 anni ( 20 %).


Scoprire le aziende in crescita